Journal Title:Research And Reviews In Parkinsonism
Research and Reviews in Parkinson's Disease is an internationally peer-reviewed journal dedicated to the study of Parkinson's disease and its related disorders. The journal aims to provide a platform for publishing articles on the latest research, policy analysis, phenomenological exploration, literature review, historical studies, and treatment progress related to Parkinson's disease. The journal covers a wide range of types of Parkinson's syndrome, including typical and atypical cases, drug-induced Parkinson's disease, secondary Parkinson's disease, and genetic degenerative diseases, as well as other motor disorders with overlapping features.
The characteristics of the magazine lie in its emphasis on original research and its contribution to improving public understanding of Parkinson's disease and its impact. The journal ensures that the published research has high academic standards and clinical relevance through a rigorous peer review process. In addition, the magazine also focuses on innovative methods for treating Parkinson's disease, including emerging drug therapies, gene therapies, cell transplantation techniques, and other potential intervention targets.
《帕金森病的研究與評(píng)論》是一本專(zhuān)注于帕金森病及其相關(guān)疾病研究的國(guó)際同行評(píng)審期刊。該雜志旨在提供一個(gè)平臺(tái),用于發(fā)表關(guān)于帕金森病的最新研究、政策分析、現(xiàn)象學(xué)探討、文獻(xiàn)回顧、歷史研究以及治療進(jìn)展的文章。期刊內(nèi)容廣泛覆蓋了多種類(lèi)型的帕金森綜合征,包括典型和非典型病例、藥物誘導(dǎo)的帕金森病、繼發(fā)性帕金森病以及遺傳性退行性疾病,以及具有重疊特征的其他運(yùn)動(dòng)障礙。
雜志的特點(diǎn)在于其對(duì)原創(chuàng)性研究的重視,以及對(duì)提高公眾對(duì)帕金森病及其影響的理解的貢獻(xiàn)。期刊通過(guò)嚴(yán)格的同行評(píng)審流程,確保發(fā)表的研究具有高學(xué)術(shù)標(biāo)準(zhǔn)和臨床相關(guān)性。此外,該雜志還關(guān)注帕金森病治療的創(chuàng)新方法,包括新興的藥物治療、基因治療、細(xì)胞移植技術(shù)以及其他潛在的干預(yù)靶點(diǎn)。
Research And Reviews In Parkinsonism由Dove Medical Press出版商出版,收稿方向涵蓋CLINICAL NEUROLOGY全領(lǐng)域,平均審稿速度 16 Weeks ,影響因子指數(shù)0.5,該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單,廣大學(xué)者值得一試。
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:CLINICAL NEUROLOGY | ESCI | Q4 | 262 / 277 |
5.6% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:CLINICAL NEUROLOGY | ESCI | Q4 | 269 / 278 |
3.42% |
名詞解釋?zhuān)?br />WOS即Web of Science,是全球獲取學(xué)術(shù)信息的重要數(shù)據(jù)庫(kù),Web of Science包括自然科學(xué)、社會(huì)科學(xué)、藝術(shù)與人文領(lǐng)域的信息,來(lái)自全世界近9,000種最負(fù)盛名的高影響力研究期刊及12,000多種學(xué)術(shù)會(huì)議多學(xué)科內(nèi)容。給期刊分區(qū)時(shí)會(huì)按照某一個(gè)學(xué)科領(lǐng)域劃分,根據(jù)這一學(xué)科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會(huì)在高分區(qū)中,最后的劃分結(jié)果分別是Q1,Q2,Q3,Q4,Q1代表質(zhì)量最高。
是否OA開(kāi)放訪問(wèn): | h-index: | 年文章數(shù): |
開(kāi)放 | -- | 0 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來(lái)源于搜索引擎): | 開(kāi)源占比(OA被引用占比): |
100.00% | 0.5 | |
研究類(lèi)文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國(guó)際期刊預(yù)警名單(試行)》名單: |
0.00% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標(biāo)和發(fā)文量:
歷年自引數(shù)據(jù):
若用戶(hù)需要出版服務(wù),請(qǐng)聯(lián)系出版商。